Takeda Pharmaceutical Co Ltd logo

Takeda Pharmaceutical Co Ltd

NEW
TSE:4502 (Japan)   Ordinary Shares
円 5,769 +67 (+1.18%) Aug 19
At Loss
P/B:
1.21
Market Cap:
円 9.21T ($ 58.10B)
Enterprise V:
円 13.63T ($ 85.93B)
Volume:
6.78M
Avg Vol (2M):
4.08M
Trade In:

Takeda Pharmaceutical Co Ltd’s share price is 円5769. Its GF Value is 円4555.17. Based on the relationship between the current stock price and the GF Value, GuruFocus believes Takeda Pharmaceutical Co Ltd stock is .

The GF Value represents the current intrinsic value of a stock derived from our proprietary algorithm. It is based primarily on the historical multiples of where the stocks have been traded and the future growth of the business, adjusted for the past returns and growth. The GF Value has been verified by backtesting and daily updated model portfolios.

GF Value Growth:

In addition to considering the current valuation, the growth potential of a company's value is equally important. Companies with faster growth rates tend to increase their value more quickly. Therefore, it's essential to look at the Price-to-Future GF Value ratios as well. The results are shown below:

Price: 円5769 GF Value Price/GF Value
Current 円4555.17 1.27
Next FY1 End 円4590.06 1.26
Next 12 Month 円4621.99 1.25
Next FY2 End 円4666.45 1.24
Correlation Analysis
Summary:

GuruFocus performed a correlation analysis comparing Takeda Pharmaceutical Co Ltd's stock price with key financial metrics: revenue per share, book value per share, EPS without NRI, and operating cash flow per share.

The analysis reveals the strongest correlation between Takeda Pharmaceutical Co Ltd's stock price and Revenue per share, with a coefficient of 74%. This is followed by a 72% correlation with Book Value per share. Takeda Pharmaceutical Co Ltd’s stock price shows no significant correlation with Operating Cash Flow per share. Takeda Pharmaceutical Co Ltd’s stock price shows no significant correlation with Earnings without NRI per share.

Historical Trends of Key Valuation Ratios
GF Value of Related Companies